@article{2f369e534d3a4c63aeca2f699e2070b5,
title = "The comorbidity of ADHD and autism spectrum disorder",
abstract = "ADHD and autism spectrum disorder are common psychiatric comorbidities to each another. In addition, there is behavioral, biological and neuropsychological overlap between the two disorders. There are also several important differences between autism spectrum disorder and ADHD. Treatment strategies for the comorbid condition will also be reviewed. Future areas of research and clinical need will be discussed.",
keywords = "ADHD, ASD, adolescent, autism spectrum, children, comorbidity, developmental disorder",
author = "Antshel, {Kevin M.} and Yanli Zhang-James and Faraone, {Stephen V.}",
note = "Funding Information: In the past year, SV Faraone has received consulting income and/or research support from Akili Interactive Labs, VAYA Pharma and Syn-apDx, and research support from the National Institutes of Health. SV Faraone{\textquoteright}s institution is seeking a patent for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. In previous years, SV Farone has received consulting fees or was on Advisory Boards or participated in continuing medical education programs sponsored by Shire, Alco-bra, Otsuka, McNeil, Janssen, Novartis, Pfizer and Eli Lilly. SV Faraone receives royalties from books published by Guilford Press (Straight Talk about Your Child{\textquoteright}s Mental Health) and Oxford University Press (Schizophrenia: The Facts). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.",
year = "2013",
doi = "10.1586/14737175.2013.840417",
language = "English (US)",
volume = "13",
pages = "1117--1128",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Taylor and Francis Ltd.",
number = "10",
}